Midodrine: a selective α-adrenergic agonist for orthostatic hypotension and dialysis hypotension

Bibliography

• KAUFFMAN H, BRANNAN T, KRAKOFF L, YAHR MD, MANDELI J: Treatment of orthostatic hypotension due to autonomic failure with a peripheral alpha-adrenergic agonist (midodrine). Neurology (1988) 38:951–956.
   PubMedGoogle Scholar
• SCHIRGER A, SHEPS SG, THOMAS JE, FEALEY RD: Midodrine: a new agent in the management of idiopathic orthostatic hypotension and Shy-Drager syndrome. Mayo Clinic Proc. (1981) 56:429–433.
   PubMedGoogle Scholar
• JANKOVIC J, GILDEN JL, HINER BC et al.: Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine. Am. J. Med. (1993) 95:38–48.
   PubMed Web of Science ®Google Scholar
• •Randomised trial of midodrine for neurogenic orthostatic hypotension.
   Google Scholar
• LOW PA, GILDEN JL, FREEMAN R, SHENG KN, MCELLIGOTT MA: Efficacy of midodrine vs. placebo in neurogenic orthostatic hypotension: a randomized, double-blind multicenter study. JAMA (1997) 277:1046–1051.
   Google Scholar
• FOUAD-TARAZI FM, OKABE M, GOREN H: Alphasympathomimetic treatment of autonomic insuffi-ciency with orthostatic hypotension. Am.J. Med. (1995) 99:604–610.
   PubMed Web of Science ®Google Scholar
• MCTAVISH D, GOA KL: Midodrine: a review of its pharmacologic properties and therapeutic use in orthostatic hypotension and secondary hypotensive disorders. Drugs (1989) 38:757–777.
   PubMed Web of Science ®Google Scholar
• ••Pharmacologic overview of midodrine.
   Google Scholar
• PERAZELLA MA: Midodrine: a new therapy for intradia- lytic hypotension. Semin. Dialysis (1997) 10:245–247.
   Web of Science ®Google Scholar
• CRUZ DN, MAHNENSMITH RL, PERAZELLA MA Intradia- lytic hypotension: is midodrine beneficial in symptomatic hemodialysis patients? Am. J. Kidney Dis. (1997) 30:772–779.
   PubMed Web of Science ®Google Scholar
• •Cross-over study of midodrine for dialysis hypotension.
   Google Scholar
• CRUZ DN, MAHNENSMITH RL, BRICKEL HM, PERAZELLA MA: Midodrine and cool dialys ate are effective therapies for symptomatic intradialytic hypotension. Am. J. Kidney Dis. (1999) 35:920–926.
   Google Scholar
• ••Direct comparison of the two treatments for dialysis-hypotension.
   Google Scholar
• CRUZ DN, MAHNENSMITH RL, BRICKEL HM, PERAZELLA MA: Midodrine is effective and safe therapy for intradialytic hypotension over 8 months of follow-up. Clin. Nephrol. (1998) 50:101–107.
   PubMed Web of Science ®Google Scholar
• BLOWEY DL, BALFE JW, GUPTA I, GAJARIA MM, KOREN G: Midodrine efficacy and pharmacoltinetics in a patient with recurrent intradialytic hypotension. Am. J. Kidney Dis. (1996) 28:132–136.
   PubMedGoogle Scholar
• ••Includes pharmacokinetics of midodrine in haemodialysis.
   Google Scholar
• FLYNN JJ, MITCHELL MC, CARUSO FS, MCELLIGOTT MA: Midodrine treatment for patients with hemodialysis hypotension. Clin. Nephrol. (1996) 45:261–267.
   PubMed Web of Science ®Google Scholar
• FANG JT, HUANG CC: Midodrine hydrochloride in patients on hemodialysis with chronic hypotension. Renal Failure (1996) 18:253–260.
   PubMed Web of Science ®Google Scholar
• LIM PS, YANG CC, LI HP, LIM YT, YEH CH: Midodrine forthe treatment of intradialytic hypotension. Nephron (1997) 77:279–283.
   PubMedGoogle Scholar
• PIWINSKI SE, JANKOVIC J, MCELLIGOTT MA: A comparison of postspace-flight orthostatic intoler-ance to vasovagal syncope and autonomic failure and the potential use of the alpha agonist midodrine for these conditions. J. Clin. Pharmacol. (1994) 24:466–471.
   Google Scholar
• MASKALL DD, LAM RW: Midodrine for TCA-induced orthostatic hypotension. J. Psych. Neurosci. (1993) 18:276–177.
   PubMedGoogle Scholar
• HIRAYAMA M, WATANABE H, KOIKE Y et al.: Treatmentof postprandial hypotension with selective alpha 1 and beta 1 adrenergic agonists. J. Auton. Nervous Sys. (1993) 45:149–154.
   PubMedGoogle Scholar
• RILEY AJ, RILEY EJ: Partial ejaculatory incompetence:the therapeutic effect of midodrine, an orally selective alpha-adrenoreceptor antagonist. Eur. Urol. (1982) 8:155–160.
   PubMedGoogle Scholar
• GAROFALO F, LALANNA GM, NANNI G: Midodrine forfemale incontinence: a preliminary report. Clin. Ther. (1986) 9:44–46.
   PubMedGoogle Scholar
• MARINI U, CECCHI A, VENTURINI M: Controlled clinicalinvestigation of dimetophrine versus midodrine in the management of moderately decreased arterial blood pressure. Curr. Med. Res. opin. (1984) 9:265–274.
   PubMed Web of Science ®Google Scholar
• ROBERTSON D, DAVIS TL: Recent advances in the treatment of orthostatic hypotension. Neurology (1995) 45:S26–S32.
   Google Scholar
• STEINBACH K, WEIDINGER P: The effect of midodrineon orthostatic hypotension. Wienier Klinische Wochen-schrzft (1973) 85:621–624.
   PubMedGoogle Scholar
• ZACHARIAH PK, BLOEDOW DC, MOYER TP, SHEPS SG, SCHIRGER A, FEALEY RD: Pharmacodynamics of midodrine, an antihypotensive agent. Clin. Pharmacol. Ther. (1986) 39:586–591.
   PubMedGoogle Scholar
• WRIGHT RA, KAUFMANN HC, PERERA R et al.: A double blind, dose-response study of midodrine in neurogenic orthostatic hypotension. Neurology (1998) 51:120–124.
   PubMed Web of Science ®Google Scholar
• SHERMAN RA: The pathophysiologic basis for hemodialysis-related hypotension. Semin. Dialysis (1988) 1:136–142.
   Google Scholar
• •Overview of dialysis hypotension.
   Google Scholar
• CONVERSE RL, JACOBSEN TN, JOST CMT et al.: Paradoxical withdrawal of reflex vasoconstriction as a cause of hemodialysis-induced hypotension. J. Clin. Invest. (1992) 90:1657–1665.
   PubMed Web of Science ®Google Scholar
• LINDBERG JS, COPLEY JB, MELTON K, WADE CE, ABRAMS J, GOODE D: Lysine vasopressin in the treatment of refractory hemodialysis-induced hypotension. Am. J. Nephrol. (1990) 10:269–275.
   PubMedGoogle Scholar
• AHMAD S, ROBERTSON MT, GOLPER TA et al.: Multicenter trial of L-carnitine in maintenance hemodialysis patients. H. Clinical and biochemical effects. Kidney Int (1990) 38:912–918.
   PubMed Web of Science ®Google Scholar
• HIRSZEL IP, MARTIN RH, MIZELL MW, NOLPH KD: Uremic autonomic neuropathy: evaluation of ephedrine sulphate therapy for hemodialysis-induced hypoten-sion. Int. Urol. Nephrol. (1976) 8:313–321.
   PubMedGoogle Scholar
• VELEZ RL, WOODWARD TD, HENRICH WL: Acetate and bicarbonate hemodialysis in patients with and without autonomic dysfunction. Kidney Int. (1984) 26:59–65.
   PubMedGoogle Scholar
• BARAKAT MM, NAWAD ZM, YU AW, LAU AH, ING TS, DAUGIRDAS JT: Hemodynarnic effects of intradialytic food ingestion and the effects of caffeine. J. Am. Soc. Nephrol. (1993) 3:1813–1818.
   PubMedGoogle Scholar
• HENRICH WL, WOODARD TD, MCPHAUL JJ: The chronic efficacy and safety of high sodium dialysate: double-blindcrossover study. Am.J. Kidney Dis(1982) 2:349–353.
   PubMedGoogle Scholar
• DAUGIRDAS JT, AL-KUDSI RR, ING TS, NORUSIS MJ: A double-blind evaluation of sodium gradient hemodialysis. Am. J. Nephrol. (1985) 5:163–168.
   PubMedGoogle Scholar
• SHERMAN RA, RUBIN MP, CODY RP, EISINGER RP: Amelioration of hemodialysis associated hypotension by the use of cool dialysate. Am. J. Kidney Dis. (1985) 5:124–127.
   PubMedGoogle Scholar
• MARCEN R, QUEREDA C, OROFINO L et al.: Hemodialysis with low temperature dialysate: a long-term experi-ence. Nephron (1988) 49:29–32.
   PubMedGoogle Scholar
• JOST CM, AGARWAL R, KHAUR-EL-DIN T, GRAYBURN PA, VICTOR RG, HEINRICH WL: Effects of cooler tempera-ture dialysate on hemodynamic stability in 'problem' dialysis patients. Kidney Int. (1993) 44:606–612.
   PubMed Web of Science ®Google Scholar